Share this page:

News

Swift Biosciences Launches Swift 2S Turbo Library Kit, Accelerating Whole Genome, Exome and Large Gene Studies with One Universal Approach

(ANN ARBOR, Mich. – July 18, 2018) Swift Biosciences, a leading provider of innovative library prep solutions for next-generation sequencing (NGS), today announced early access to its Swift 2S Turbo Library Kit. These new kits offer a fast, robust enzymatic fragmentation prep and flexible adapter options to produce high-quality libraries for production-scale sequencing. With an automation

More »

Swift Biosciences and Genomenon Announce Partnership to Accelerate Biomarker Selection for Targeted NGS Panels

Two Ann Arbor biotech companies provide translational researchers a faster, more comprehensive way to design Accel-Amplicon panels for variant discovery and screening studies (ANN ARBOR, Michigan – May 23, 2018) – Swift Biosciences—the NGS Library Prep company—and Genomenon—the leading genomic literature search engine company— announced today a new partnership to revolutionize the design of targeted

More »

Swift Biosciences Builds on Momentum, Accelerates Growth with Addition of Nathan Wood as New CEO

Results-driven, customer-focused leader to drive continued expansion in personalized medicine, disease research markets (ANN ARBOR, Mich. – May 22, 2018) Swift Biosciences, a leading provider of innovative library prep solutions for genomic sequencing, today named industry veteran Nathan Wood as its new CEO. The hire is the latest in a recent series of strategic moves

More »

Swift Biosciences Launches Accel-Amplicon™ Plus Cancer Panels for Precision Medicine Initiatives

New targeted sequencing workflow combines pre-validated content with easy customization and new analysis tools to accelerate variant discovery and screening (ANN ARBOR, Mich. – April 18, 2018) Swift Biosciences today announced the commercial release of its Accel-Amplicon™ Plus Cancer Panels, a suite of nine tumor-specific and focused gene panels to facilitate targeted cancer sequencing. The Accel-Amplicon technology

More »

Swift Biosciences Launches Unique Dual Indexing Kits to improve Multiplexed Next Generation Sequencing

New Accel-NGS Unique Dual Indexing Kits minimize read misassignments for higher quality results (ANN ARBOR, Mich. – April 6, 2018) Swift Biosciences today announced the launch of its Accel-NGS® Unique Dual Indexing Kits, which deliver the power and value of high-throughput multiplexed sequencing while improving the accuracy of low frequency variant calling, such as somatic mutations, in

More »

Swift Launches Accel-Amplicon™ Custom NGS Panels, Accelerating Variant Discovery in Challenging Biological Samples

Genialis/Swift partnership delivers a complete targeted sequencing solution with intuitive analysis software (ANN ARBOR, Mich. – Oct. 12, 2017) Swift Biosciences, a leading provider of innovative library prep solutions for next-generation sequencing (NGS), today announced the launch of its Accel-Amplicon™ Custom NGS Panels. These new panels offer a targeted DNA sequencing product that enables clinical researchers

More »

Swift Biosciences Growth Sparks Expansion into New Headquarters & First West Coast Office

Michigan company doubles size of Ann Arbor-based operations and expands to San Francisco with new commercial office space (ANN ARBOR, Mich. and SOUTH SAN FRANCISCO – October 5, 2017) Swift Biosciences, a leading provider of innovative library-prep solutions for genomic sequencing, today announced the move and expansion of their headquarters in Ann Arbor, Michigan, and the

More »

Swift Announces the Highest Throughput Single-Cell Methyl-Seq Library Preparation Method

Study published in Science magazine demonstrates how epigenetic markers can identify cell subtypes and regulatory elements that drive cellular diversity (ANN ARBOR, Mich. – August 10, 2017) Swift Biosciences, a leading provider of innovative library prep solutions for next-generation sequencing (NGS), today announced the launch of a new single-cell methylation sequencing method based on its Accel-NGS®

More »

Swift Biosciences Announces New Industry-Leading Indexed Adapters for Sequencing Larger Numbers of Samples in a Single Run

Revolutionary technology will accelerate utility of gene mapping, biomarker discovery, tumor profiling, and liquid biopsy analysis. Swift Biosciences, a leading provider of innovative library prep solutions for genomic sequencing, today announced the launch of Accel-NGS® 2S Indexed Adapters, a new portfolio of indices that significantly improves multiplexed next-generation

More »

Swift Biosciences Launches Next Phase of Company Growth and Expansion

Company completes Series D funding and adds two new directors to board. Swift Biosciences, a leading provider of innovative library prep solutions for genomic sequencing, today announced the completion of a Series D funding raise of $12.2 million. The company also announced the addition of two new directors to its board, positioning the company for accelerated growth. The Series D round was led by Arboretum Ventures

More »